Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
Objective To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to
screen for prostate cancer. Design Systematic review and meta-analysis. Data sources …
screen for prostate cancer. Design Systematic review and meta-analysis. Data sources …
Prostate cancer mortality in the Finnish randomized screening trial
TP Kilpeläinen, TL Tammela, N Malila… - Journal of the …, 2013 - academic.oup.com
Background Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …
shown to decrease PC mortality by the European Randomized Study of Screening for …
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer
MJ Roobol, R Kranse, CH Bangma, AG van Leenders… - European urology, 2013 - Elsevier
Background Evidence from randomized trials on the effects of screening for prostate cancer
(PCa) on disease-specific mortality accumulates slowly with increasing follow-up. Objective …
(PCa) on disease-specific mortality accumulates slowly with increasing follow-up. Objective …
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
J Hugosson, MJ Roobol, M Månsson, TLJ Tammela… - European urology, 2019 - Elsevier
Abstract Background The European Randomized study of Screening for Prostate Cancer
(ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening …
(ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening …
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence
JH Hayes, MJ Barry - Jama, 2014 - jamanetwork.com
Importance Prostate cancer screening with the prostate-specific antigen (PSA) test remains
controversial. Objective To review evidence from randomized trials and related modeling …
controversial. Objective To review evidence from randomized trials and related modeling …
Prostate-specific antigen-based screening: controversy and guidelines
EH Kim, GL Andriole - BMC medicine, 2015 - Springer
Although prostate-specific antigen (PSA) screening has improved the detection of prostate
cancer, allowing for stage migration to less advanced disease, the precise mortality benefit …
cancer, allowing for stage migration to less advanced disease, the precise mortality benefit …
Screening and prostate-cancer mortality in a randomized European study
FH Schröder, J Hugosson, MJ Roobol… - New England journal …, 2009 - Mass Medical Soc
Background The European Randomized Study of Screening for Prostate Cancer was
initiated in the early 1990s to evaluate the effect of screening with prostate-specific–antigen …
initiated in the early 1990s to evaluate the effect of screening with prostate-specific–antigen …
Prostate-specific antigen–based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force
Importance Prostate cancer is the second leading cause of cancer death among US men.
Objective To systematically review evidence on prostate-specific antigen (PSA)–based …
Objective To systematically review evidence on prostate-specific antigen (PSA)–based …
[HTML][HTML] Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
S Cabarkapa, M Perera, S McGrath… - Prostate …, 2016 - Elsevier
Background Prostate cancer remains the most common non-skin cancer malignancy in men.
Prostate-specific antigen (PSA) is recognized as a biomarker for the diagnosis, monitoring …
Prostate-specific antigen (PSA) is recognized as a biomarker for the diagnosis, monitoring …
Prostate cancer mortality reduction by prostate-specific antigen–based screening adjusted for nonattendance and contamination in the European Randomised Study …
BACKGROUND: Prostate-specific antigen (PSA) based screening for prostate cancer (PCa)
has been shown to reduce prostate specific mortality by 20% in an intention to screen (ITS) …
has been shown to reduce prostate specific mortality by 20% in an intention to screen (ITS) …